AbCellera Biologics Inc.ABCL

AbCellera Biologics Inc. Revenue Disclosure

10-KFiled Feb 24, 20261 min read
Revenue
The disaggregated revenue categories are presented on the consolidated statements of loss and comprehensive loss.
Deferred Revenue
Deferred revenue represents payments received for performance obligations not yet satisfied and is presented as current or long-term in the accompanying consolidated balance sheets based on the expected timing of satisfaction of the underlying goods and/or services.
Deferred revenue outstanding at each respective period is as follows:
December 31,
20242025
Deferred revenue$19,221 $17,026 
During the years ended December 31, 2023, 2024 and 2025, the Company recognized $17.0 million, $20.6 million and $11.8 million, respectively, of revenue that had been included in deferred revenue in the previous year.
Of the deferred revenue balance related to various agreements, approximately $13.5 million is expected to be recognized in revenue in the next 12 months.

Historical Timeline

Fiscal YearFiled
2025Feb 24, 2026Showing above
2024Feb 27, 2025
2023Feb 20, 2024
2022Feb 21, 2023
2021Feb 25, 2022

About Revenue Disclosures

Revenue disclosures under ASC 606 explain how a company identifies performance obligations, allocates transaction prices, and determines when revenue is recognized. This section is essential for understanding whether reported revenue reflects genuine economic activity or aggressive accounting choices. Analysts examine the mix of point-in-time versus over-time recognition, which directly affects revenue timing and comparability.

Key signals: rising contract liabilities (deferred revenue) suggest strong future revenue visibility, while declining contract assets may indicate slowing project milestones. Watch for variable consideration estimates — rebates, returns, and performance bonuses that require management judgment. Significant changes in disaggregated revenue by geography or product line can reveal shifting business mix before it appears in headline numbers. Compare revenue growth against contract liability growth to assess sustainability, and scrutinize any changes in the timing of recognition that coincide with earnings pressure.

Other Available Disclosures

Income TaxesEarnings Per SharePP&EGoodwill & IntangiblesLeasesCommitmentsNew StandardsPay vs Performance